Home›Search›Recent Advances in Anti-Infective Drug Discovery

Recent Advances in Anti-Infective Drug Discovery

Bentham Science Publishers · United Arab Emirates · Est. 1998

ISSN2772-4352

SJR Q3✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q354

Total54

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 75% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Scorei

0.304

H-Indexi

SNIPi

0.346

Total Worksi

143

Total Citationsi

391

2yr Mean Citednessi

0.73

Open Impact Factor alternative

Aims & Scope

Subject areas: Drug Discovery; Infectious Diseases; Pharmacology (medical).

General Information

Country / RegionUnited Arab Emirates

Primary Language—

1st Year Published1998

Annual Volume~ 22 articles / year

StatusActive (last: 2026)

Total Publications143

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Bentham Science Publishers

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2772-4352

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

1998

2020

137

2021

147

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ3

Infectious DiseasesQ3

Pharmacology (medical)Q3

Subject Classification

Scopus Categories

Drug DiscoveryPharmacology (medical)Infectious Diseases

Research Topics (OpenAlex)

COVID-19 Clinical Research StudiesDiverse Scientific and Economic StudiesDiverse Scientific Research StudiesSARS-CoV-2 and COVID-19 ResearchAntibiotic Resistance in BacteriaAntibiotic Use and ResistanceSynthesis and biological activityNail Diseases and TreatmentsHuman auditory perception and evaluationAntifungal resistance and susceptibility

Frequently asked questions about Recent Advances in Anti-Infective Drug Discovery

Is Recent Advances in Anti-Infective Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Recent Advances in Anti-Infective Drug Discovery: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 54/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Recent Advances in Anti-Infective Drug Discovery?

Recent Advances in Anti-Infective Drug Discovery is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.304.

Is Recent Advances in Anti-Infective Drug Discovery indexed in Scopus and Web of Science?

Recent Advances in Anti-Infective Drug Discovery is indexed in Scopus.

What is the aims and scope of Recent Advances in Anti-Infective Drug Discovery?